Heparanase Gene Hypomethylation as a Potential Biomarker for Precision Screening of Bladder Cancer
Background: Epigenetics has been playing an increasingly important role in the study of the origin and development of bladder cancer (BC). This study aimed to investigate the correlation between promoter hypomethylation of the heparanase (HPSE) gene and clinicopathologic characteristics of bladder c...
Main Authors: | Bai-sheng Xu, Yan-ying Jiang, Caizhi Liao, Min-bo Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hormozgan University of Medical Sciences
2022-07-01
|
Series: | Disease and Diagnosis |
Subjects: | |
Online Access: | https://ddj.hums.ac.ir/PDF/ddj-11-100.pdf |
Similar Items
-
Heparanase-1: From Cancer Biology to a Future Antiviral Target
by: Nadjet Lebsir, et al.
Published: (2023-01-01) -
DNA hypomethylation mediates immune response in pan-cancer
by: Chunlong Zhang, et al.
Published: (2023-12-01) -
Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer
by: Hanyu Cao, et al.
Published: (2020-10-01) -
Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential
by: Fengyan Yuan, et al.
Published: (2022-09-01) -
Promoter hypomethylation and overexpression of TSTD1 mediate poor treatment response in breast cancer
by: Muhamad Ansar, et al.
Published: (2022-11-01)